Yuyu Pharma, Inc.
Financials
Valuation Metrics
Yuyu Pharma, Inc.'s Market Cap is ₩678B. At end of 2025 it was ₩865B. Ranked #1495 of 2,405 in KR market (top 62%), #634 of 778 on KOSPI (top 81%), #161 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 70%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 67.84B KRW | KR#1,495/2,405 Sec#161/231 |
| Revenue | 144.37B KRW | KR#1,206/2,405 Sec#72/231 |
| Net Income | 12.43B KRW | KR#892/2,405 Sec#58/231 |
| Total Assets | 207.88B KRW | KR#1,285/2,405 Sec#93/231 |
| Net Assets | 146.18B KRW | KR#1,154/2,405 Sec#83/231 |
| Employees | 257 | KR#909/2,405 Sec#76/231 |
| Value | ||
| P/E | 5.46x | KR#454/2,405 Sec#18/231 |
| P/B | 0.46x | KR#799/2,405 Sec#32/231 |
| P/S | 0.47x | KR#927/2,405 Sec#42/231 |
| EV/EBITDA | 6.00x | KR#344/2,405 Sec#10/231 |
| FCF Yield | 11.24% | KR#599/2,405 Sec#24/231 |
| Profitability | ||
| ROE | 8.50% | KR#738/2,405 Sec#52/231 |
| ROA | 5.98% | KR#629/2,405 Sec#50/231 |
| Op. Margin | 9.12% | KR#580/2,405 Sec#49/231 |
| Revenue Growth | 6.69% | KR#1,085/2,405 Sec#105/231 |
| Financial Health | ||
| Debt Ratio | 42.21% | KR#834/2,405 Sec#97/231 |
| Total Debt | 32.18B KRW | KR#1,187/2,405 Sec#88/231 |
| FCF | 7.62B KRW | KR#789/2,405 Sec#47/231 |
| Cash | 20.99B KRW | KR#1,226/2,405 Sec#89/231 |
| Current Ratio | 1.89x | KR#916/2,405 Sec#103/231 |
| Net Debt/EBITDA | 0.85x | KR#717/2,405 Sec#48/231 |
| Dividend | ||
| Div. Yield | 3.12% | KR#654/2,405 Sec#31/231 |
| Div. Growth | 15.00% | KR#509/2,405 Sec#28/231 |
| Performance | ||
| 1Y Return | -11.81% | KR#867/2,405 Sec#50/231 |
| 1M Return | -3.17% | KR#551/2,405 Sec#52/231 |
| From 52W High | -28.24% | KR#363/2,405 Sec#22/231 |
| 1Y MDD | -27.53% | KR#177/2,405 Sec#11/231 |
| Trading | ||
| Volume | 27,909 shares | KR#1,319/2,405 Sec#129/231 |
| Trading Value | 102.3M KRW | KR#1,429/2,405 Sec#154/231 |
| Foreign Own. | 2.60% | KR#1,419/2,405 Sec#133/231 |
| Per Share | ||
| EPS | 671 KRW | KR#881/2,405 Sec#62/231 |
| BPS | 7,886 KRW | KR#1,142/2,405 Sec#83/231 |
Company Info
Established in 1941 as Yuhan Trading and listed on the securities market in 1975, the company is a pharmaceutical firm manufacturing and selling pharmaceuticals and health functional foods from its plant in Jecheon, Chungcheongbuk-do. It supplies specialized pharmaceuticals to domestic hospitals and clinics, operates a contract manufacturing business, and exports finished pharmaceuticals to various countries. With subsidiaries including YUYU Healthcare, YUYU Medicals, and YUYU VENTURES, the company is diversifying its business, including expansion into animal pharmaceuticals. The company is headquartered in Jecheon, Chungcheongbuk-do.